scholarly article | Q13442814 |
P356 | DOI | 10.1002/IJC.28988 |
P698 | PubMed publication ID | 24945890 |
P50 | author | Steven A. Narod | Q50384888 |
Cezary Cybulski | Q42590472 | ||
P2093 | author name string | Safia Nazarali | |
P2860 | cites work | Linkage of ATM to cell cycle regulation by the Chk2 protein kinase | Q22008502 |
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome | Q22011001 | ||
Mutations of two PMS homologues in hereditary nonpolyposis colon cancer | Q24318484 | ||
von Hippel-Lindau disease: a clinical and scientific review | Q24622030 | ||
Meta-analysis of BRCA1 and BRCA2 penetrance | Q24654786 | ||
Will the real Cowden syndrome please stand up: revised diagnostic criteria | Q24681567 | ||
The pathology of familial breast cancer: Morphological aspects | Q24800393 | ||
Mutation of a mutL homolog in hereditary colon cancer | Q28114939 | ||
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 | Q28212276 | ||
Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH | Q28212369 | ||
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations | Q28215462 | ||
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer | Q28257360 | ||
Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer | Q28260081 | ||
Colorectal cancer due to deficiency in DNA mismatch repair function: a review | Q28262308 | ||
Cancer genes and the pathways they control | Q28275089 | ||
Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms | Q29618586 | ||
Identification of the von Hippel-Lindau disease tumor suppressor gene | Q29618644 | ||
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium | Q29619206 | ||
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews | Q29619407 | ||
Realizing the promise of cancer predisposition genes | Q30743260 | ||
Von Hippel-Lindau disease: a genetic study | Q33597245 | ||
Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers | Q33795280 | ||
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype | Q33904762 | ||
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics | Q34015399 | ||
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas | Q34020549 | ||
Germline p16 mutations in familial melanoma | Q34059915 | ||
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? | Q34232464 | ||
BRCA1-positive breast cancers in young women from Poland. | Q44949616 | ||
Multiple primary cancers in families with Li-Fraumeni syndrome | Q44955059 | ||
Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families | Q45243999 | ||
The risk of gastric cancer in carriers of CHEK2 mutations | Q45259012 | ||
Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations | Q47645440 | ||
Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome | Q47762736 | ||
The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. | Q50601473 | ||
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. | Q50680047 | ||
Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. | Q51421155 | ||
Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. | Q54441713 | ||
Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP). | Q54441823 | ||
A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in theCDKN2Tumor-Suppressor Gene | Q55670980 | ||
Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families | Q56436681 | ||
High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL | Q56437244 | ||
A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene | Q56438525 | ||
Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation | Q56456411 | ||
Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations | Q57250780 | ||
Is CHEK2 a cause of the Li Fraumeni syndrome? | Q57266694 | ||
Risk of Cancer in Relatives of Prostate Cancer Probands | Q57307341 | ||
Clinical Implications of the Colorectal Cancer Risk Associated With MUTYH Mutation | Q57319696 | ||
Double primary cancers of the breast and thyroid in women: molecular analysis and genetic implications | Q59238491 | ||
Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register | Q34252458 | ||
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families | Q34387715 | ||
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group | Q34512590 | ||
LINDAU'S DISEASE. REVIEW OF THE LITERATURE AND STUDY OF A LARGE KINDRED. | Q34540867 | ||
A high proportion of founder BRCA1 mutations in Polish breast cancer families | Q34548008 | ||
CHEK2 is a multiorgan cancer susceptibility gene | Q34551970 | ||
Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations? | Q34572576 | ||
E-cadherin germline mutations in familial gastric cancer. | Q34746744 | ||
Pancreatic carcinoma surveillance in patients with familial melanoma | Q35202340 | ||
Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9. | Q35357970 | ||
Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations | Q35597950 | ||
Site-specific familial aggregation of prostate cancer. | Q35678492 | ||
Lifetime cancer risks in individuals with germline PTEN mutations. | Q35681689 | ||
The risk of breast cancer in women with a BRCA1 mutation from North America and Poland | Q35907001 | ||
The genetics of FAP and FAP-like syndromes | Q36602699 | ||
CHEK2 variants associate with hereditary prostate cancer | Q36671622 | ||
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts | Q36824964 | ||
The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype | Q37147694 | ||
Mutations in CHEK2 associated with prostate cancer risk | Q37219438 | ||
Pathological features of colorectal carcinomas in MYH-associated polyposis | Q37368316 | ||
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition | Q37542430 | ||
Jejunal cancer in patients with familial adenomatous polyposis | Q37732936 | ||
Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria | Q38153670 | ||
High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis | Q38855823 | ||
Familial cancer syndromes: A survey | Q39861086 | ||
Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. | Q40727923 | ||
CHEK2 I157T associates with familial and sporadic colorectal cancer | Q43169381 | ||
Tamoxifen and risk of endometrial cancer | Q43528467 | ||
Hereditary ovarian cancer in Poland. | Q43683502 | ||
The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas | Q43702401 | ||
Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors | Q43871566 | ||
Expanded extracolonic tumor spectrum in MUTYH-associated polyposis | Q44674408 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | heritability | Q1503548 |
P304 | page(s) | 1756-1763 | |
P577 | publication date | 2014-06-19 | |
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | Multiple primary cancers as a guide to heritability | |
P478 | volume | 135 |
Q89654302 | A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results |
Q43201507 | C57BL/6N Mice Are More Resistant to Ehrlich Ascites Tumors Than C57BL/6J Mice: The Role of Macrophage Nitric Oxide. |
Q28396964 | Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s |
Q37615396 | Germline large genomic alterations on 7q in patients with multiple primary cancers. |
Q92059446 | Hereditary gastric cancer: Three rules to reduce missed diagnoses |
Q92581632 | Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer |
Q64974989 | Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer. |
Q28389071 | Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma |
Q48288066 | Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families. |
Q91705887 | Prostate cancer prognosis in men with other malignancies prior to radical prostatectomy |
Q40378252 | Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development. |
Q49560859 | Reply to 'Comment on 'Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system". |
Q47653008 | Socioeconomic Status and Childhood Cancer Incidence: A Population-Based Multilevel Analysis |
Q26785320 | Synchronous double primary gastric and endometrial cancer: a case report and literature review |
Q92326922 | Synchronous multiple primary gastrointestinal cancers with CDH1 mutations: A case report |
Q36183280 | Temporal trends in the risk of developing multiple primary cancers: a systematic review. |